315. ISCAID Systemic Therapy Guidelines: Key Takeaways for GPs with Allison Inga

Send me a derm question or story through text or voicemail! Allison Inga, DVM, DACVD is back on the podcast! In this week's episode, we review the systemic antimicrobial recommendations from the International Society for Companion Animal Infectious Diseases (ISCAID) and what they mean for veterinarians treating superficial or deep pyoderma. We highlight when systemic antibiotics are truly indicated, first-line drug selection, along with more resitant infections that may require second- or third-line antibiotic treatment. The discussion also reinforces antimicrobial stewardship principles, including avoiding unnecessary use of critically important antibiotics. A focused update designed to help veterinarians and staff members to apply ISCAID guidance confidently and responsibly in everyday clinical cases. Timestamps 00:00 – Intro 01:35 – When To Use Systemic Therapy 02:32 – Topical Therapy 2-Week Period 03:35 – Different Types of Pyoderma 07:18 – First Choice Drugs 10:20 – Go-To Drug Choice 11:50 – Wiggle Room When Prescribing 14:03 – Second Choice Drugs 16:57 – Where To Dose 18:54 – Usage in Dogs 19:37 – Other Second Choice Considerations 23:09 – Usage Experience with Rifampin 25:52 – Systematic Use of Amikacin 28:03 – Chloramphenicol Use in Patients 31:08 – When To Limit Use 32:46 – Other Considerations 34:08 – Outro

You can listen to 315. ISCAID Systemic Therapy Guidelines: Key Takeaways for GPs with Allison Inga online on Radio and Podcast. Open the player on this page to stream the available audio.

315. ISCAID Systemic Therapy Guidelines: Key Takeaways for GPs with Allison Inga is an episode from The Derm Vet Podcast by Ashley Bourgeois, DVM, Dip ACVD.

This episode is 34:23 long.

This episode was published on Mar 12, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Derm Vet Podcast when more episodes are available from the podcast feed.